33-week non-inferiority of extended- vs. immediate-release pramipexole tablets in treatment of early Parkinson's disease

被引:0
|
作者
Poewe, W. [1 ]
Barone, P. [2 ]
Hauser, R. [3 ]
Mizuno, Y. [4 ]
Rascol, O. [5 ]
Schapira, A. [6 ]
Haaksma, M. [7 ]
Salin, L. [8 ]
机构
[1] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria
[2] Univ Naples Federico 2, Dept Neurol Sci, I-80138 Naples, Italy
[3] Univ S Florida, Parkinsons Dis & Movement Disorders Ctr, Tampa, FL USA
[4] Juntendo Univ, Sch Med, Dept Neurol, Tokyo 113, Japan
[5] Toulouse Univ Hosp, INSERM, Clin Invest Ctr, Toulouse, France
[6] Inst Neurol, Univ Dept Clin Neurosci, London WC1N 3BG, England
[7] Boehringer Ingelheim Pharma RCV GmbH & Co KG, Vienna, Austria
[8] Boehringer Ingelheim France SAS, Reims, France
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:28 / 28
页数:1
相关论文
共 23 条
  • [1] Extended-release pramipexole in early Parkinson disease A 33-week randomized controlled trial
    Poewe, W.
    Rascol, O.
    Barone, P.
    Hauser, R. A.
    Mizuno, Y.
    Haaksma, M.
    Salin, L.
    Juhel, N.
    Schapira, A. H. V.
    [J]. NEUROLOGY, 2011, 77 (08) : 759 - 766
  • [2] Decrease in off-time for extended- and for immediate-release pramipexole in advanced Parkinson's disease
    Schapira, A.
    Barone, P.
    Hauser, R.
    Mizuno, Y.
    Poewe, W.
    Rascol, O.
    Busse, M.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 29 - 29
  • [3] Once-daily pramipexole extended-release (ER) demonstrated non-inferiority compared to immediate release (IR) tid dosing in early Parkinson's disease
    Poewe, W.
    Barone, P.
    Hauser, R.
    Mizuno, Y.
    Rascol, O.
    Schapira, A.
    Haaksma, M.
    Juhel, N.
    Salin, L.
    [J]. PARKINSONISM & RELATED DISORDERS, 2009, 15 : S131 - S131
  • [4] Overnight Conversion from Immediate-Release to Extended-Release Pramipexole for Adjunctive Treatment of Advanced Parkinson's Disease
    Schapira, Anthony
    Barone, Paolo
    Hauser, Robert
    Mizuno, Youshikuni
    Poewe, Werner
    Rascol, Olivier
    Busse, Michael
    Salin, Laurence
    Sohr, Mandy
    [J]. NEUROLOGY, 2010, 74 (09) : A317 - A317
  • [5] Duration of "on" periods after treatment with extended-release vs. immediate-release carbidopa-levodopa in patients with advanced Parkinson's disease
    Ondo, William
    Mark, Margery
    Modi, Nishit
    Khanna, Sarita
    Gupta, Suneel
    [J]. NEUROLOGY, 2017, 88
  • [6] Overnight switch from pramipexole immediate release to pramipexole extended release in patients with early Parkinson's disease: The Switch trial
    Debieuvre, C.
    Salin, L.
    Rascol, O.
    [J]. MOVEMENT DISORDERS, 2008, 23 (01) : S201 - S201
  • [7] Immediate vs. delayed-start pramipexole in early Parkinson's disease: the PROUD study
    Schapira, A.
    Albrecht, S.
    Barone, P.
    Comella, C.
    Hsu, H.
    Massey, D.
    McDermott, M.
    Poewe, W.
    Rascol, O.
    Scrine, K.
    Marek, K.
    [J]. PARKINSONISM & RELATED DISORDERS, 2009, 15 : S81 - S81
  • [8] Role and clinical utility of pramipexole extended release in the treatment of early Parkinson's disease
    Hametner, Eva-Maria
    Seppi, Klaus
    Poewe, Werner
    [J]. CLINICAL INTERVENTIONS IN AGING, 2012, 7 : 83 - 88
  • [9] Overnight switching from immediate- to extended-release pramipexole in early Parkinson's disease
    Rascol, O.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 : 14 - 14
  • [10] Overnight Switching from Immediate- to Extended-Release Pramipexole in Early Parkinson's Disease
    Rascol, Olivier
    Barone, Paolo
    Debieuure, Catherine Deboue
    Hauser, Robert
    Mizuno, Yoshikuni
    Poewe, Werner
    Salin, Laurence
    Schapira, Anthony
    Sohr, Mandy
    [J]. NEUROLOGY, 2009, 72 (11) : A320 - A320